143 related articles for article (PubMed ID: 18566480)
41. Crystal structures of human FIH-1 in complex with quinol family inhibitors.
Moon H; Han S; Park H; Choe J
Mol Cells; 2010 May; 29(5):471-4. PubMed ID: 20396966
[TBL] [Abstract][Full Text] [Related]
42. Furan- and Thiophene-2-Carbonyl Amino Acid Derivatives Activate Hypoxia-Inducible Factor via Inhibition of Factor Inhibiting Hypoxia-Inducible Factor-1.
Kawaguchi SI; Gonda Y; Yamamoto T; Sato Y; Shinohara H; Kobiki Y; Ichimura A; Dan T; Sonoda M; Miyata T; Ogawa A; Tsujita T
Molecules; 2018 Apr; 23(4):. PubMed ID: 29641495
[TBL] [Abstract][Full Text] [Related]
43. A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1{alpha}.
Li SH; Shin DH; Chun YS; Lee MK; Kim MS; Park JW
Mol Cancer Ther; 2008 Dec; 7(12):3729-38. PubMed ID: 19074848
[TBL] [Abstract][Full Text] [Related]
44. Hinokitiol activates the hypoxia-inducible factor (HIF) pathway through inhibition of HIF hydroxylases.
Lee MJ; Kim JW; Yang EG
Biochem Biophys Res Commun; 2010 May; 396(2):370-5. PubMed ID: 20416277
[TBL] [Abstract][Full Text] [Related]
45. FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity.
Mahon PC; Hirota K; Semenza GL
Genes Dev; 2001 Oct; 15(20):2675-86. PubMed ID: 11641274
[TBL] [Abstract][Full Text] [Related]
46. Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 alpha.
Chan DA; Sutphin PD; Yen SE; Giaccia AJ
Mol Cell Biol; 2005 Aug; 25(15):6415-26. PubMed ID: 16024780
[TBL] [Abstract][Full Text] [Related]
47. HIF hydroxylation and cellular oxygen sensing.
Metzen E; Ratcliffe PJ
Biol Chem; 2004; 385(3-4):223-30. PubMed ID: 15134335
[TBL] [Abstract][Full Text] [Related]
48. The Asparagine Hydroxylase FIH: A Unique Oxygen Sensor.
Volkova YL; Pickel C; Jucht AE; Wenger RH; Scholz CC
Antioxid Redox Signal; 2022 Nov; 37(13-15):913-935. PubMed ID: 35166119
[No Abstract] [Full Text] [Related]
49. RUNX3 inhibits hypoxia-inducible factor-1α protein stability by interacting with prolyl hydroxylases in gastric cancer cells.
Lee SH; Bae SC; Kim KW; Lee YM
Oncogene; 2014 Mar; 33(11):1458-67. PubMed ID: 23542169
[TBL] [Abstract][Full Text] [Related]
50. The facial triad in the α-ketoglutarate dependent oxygenase FIH: A role for sterics in linking substrate binding to O
Hangasky JA; Taabazuing CY; Martin CB; Eron SJ; Knapp MJ
J Inorg Biochem; 2017 Jan; 166():26-33. PubMed ID: 27815979
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of a prolyl hydroxylase domain (PHD) by substrate analog peptides.
Kwon HS; Choi YK; Kim JW; Park YK; Yang EG; Ahn DR
Bioorg Med Chem Lett; 2011 Jul; 21(14):4325-8. PubMed ID: 21665470
[TBL] [Abstract][Full Text] [Related]
52. DNA methylation analysis of the HIF-1α prolyl hydroxylase domain genes PHD1, PHD2, PHD3 and the factor inhibiting HIF gene FIH in invasive breast carcinomas.
Huang KT; Mikeska T; Dobrovic A; Fox SB
Histopathology; 2010 Sep; 57(3):451-60. PubMed ID: 20727020
[TBL] [Abstract][Full Text] [Related]
53. Biochemical characterization of human HIF hydroxylases using HIF protein substrates that contain all three hydroxylation sites.
Pappalardi MB; McNulty DE; Martin JD; Fisher KE; Jiang Y; Burns MC; Zhao H; Ho T; Sweitzer S; Schwartz B; Annan RS; Copeland RA; Tummino PJ; Luo L
Biochem J; 2011 Jun; 436(2):363-9. PubMed ID: 21410436
[TBL] [Abstract][Full Text] [Related]
54. Inverse solvent isotope effects arising from substrate triggering in the factor inhibiting hypoxia inducible factor.
Hangasky JA; Saban E; Knapp MJ
Biochemistry; 2013 Mar; 52(9):1594-602. PubMed ID: 23351038
[TBL] [Abstract][Full Text] [Related]
55. A nonradioactive 96-well plate assay for the detection of hypoxia-inducible factor prolyl hydroxylase activity.
Oehme F; Jonghaus W; Narouz-Ott L; Huetter J; Flamme I
Anal Biochem; 2004 Jul; 330(1):74-80. PubMed ID: 15183764
[TBL] [Abstract][Full Text] [Related]
56. [The expression of hypoxia-inducible factor-1alpha and its hydroxylases in pulmonary arteries of patient with chronic obstructive pulmonary disease].
Chen YR; Dai AG; Hu RC; Kong CC
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 May; 28(3):234-8. PubMed ID: 22860423
[TBL] [Abstract][Full Text] [Related]
57. Enzyme-linked immunosorbent assay for pharmacological studies targeting hypoxia-inducible factor 1alpha.
Formento JL; Berra E; Ferrua B; Magné N; Simos G; Brahimi-Horn C; Pouysségur J; Milano G
Clin Diagn Lab Immunol; 2005 May; 12(5):660-4. PubMed ID: 15879029
[TBL] [Abstract][Full Text] [Related]
58. Oxygen-sensing under the influence of nitric oxide.
Berchner-Pfannschmidt U; Tug S; Kirsch M; Fandrey J
Cell Signal; 2010 Mar; 22(3):349-56. PubMed ID: 19861159
[TBL] [Abstract][Full Text] [Related]
59. The conservation and functionality of the oxygen-sensing enzyme Factor Inhibiting HIF (FIH) in non-vertebrates.
Hampton-Smith RJ; Davenport BA; Nagarajan Y; Peet DJ
PLoS One; 2019; 14(4):e0216134. PubMed ID: 31034531
[TBL] [Abstract][Full Text] [Related]
60. A fluorescence polarization-based interaction assay for hypoxia-inducible factor prolyl hydroxylases.
Cho H; Park H; Yang EG
Biochem Biophys Res Commun; 2005 Nov; 337(1):275-80. PubMed ID: 16182243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]